Skip to main content
Fig. 1 | Trials

Fig. 1

From: The effects of nano-curcumin as a nutritional strategy on clinical and inflammatory factors in children with cystic fibrosis: the study protocol for a randomized controlled trial

Fig. 1

Schematic of study design. First and second evaluations consist of the following: serum interleukin-6 (IL-6), IL-10, and high sensitivity. C-reactive protein (hs-CRP), fecal calprotectin, weight and body mass index (BMI), and score of quality of life of the cystic fibrosis questionnaire (CFQ)

Back to article page

Trials

ISSN: 1745-6215